Superficial vein thrombosis svt is less well studied than deep vein thrombosis dvt because it has been considered to be a minor self limiting disease that is easily diagnosed on clinical grounds and that requires only symptomatic relief. Outpatient treatment of dvt and low risk pe new guidelines for management of superficial vein thrombosis in may 2015 new uwmedicine guidelines for management of superficial vein thrombosis were approved.
Upper extremity deep vein thrombosis uedvt accounts for 10 of cases of deep vein thrombosis.
Basilic vein thrombosis treatment guidelines. Anticoagulation is also appropriate for those patients who demonstrate propagation. Thrombosis of superficial veins has long been regarded as a benign disorder. Either anticoagulation or serial.
If patients with a clinical diagnosis of superficial venous thrombosis svt are thoroughly evaluated the degree and extent of thrombosis in patients with svt are characteristically underestimated 75 of the time and such patients have coexistence 25 of the time of and or rapid progression 10 of. Anti coagulation for superficial vein thrombosis. 1 2 proximal uedvt is defined as thrombosis involving the axillary or more proximal deep veins and distal uedvt is defined as thrombosis of the brachial or more distal deep.
However it is noteworthy that these guidelines are based on rather weak trials. Anti coagulation heparin low molecular weight heparin or warfarin can be used to treat superficial vein thrombosis. The prevalence appears to be increasing particularly because of an increased use of indwelling central venous catheters.
The current guidelines recommend. The most frequently involved sites of the superficial ve. Duplex ultrasound may be appropriate.
Patient when thrombus approaches the deep venous system at other sites ie saphenopopliteal junction perforator veins should be individualized.